Photo from wikipedia
1 Babjuk M, Burger M, Comp erat EM et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma in situ) – 2019 update. Eur. Urol. 2019;… Click to show full abstract
1 Babjuk M, Burger M, Comp erat EM et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma in situ) – 2019 update. Eur. Urol. 2019; 76: 639–57. 2 Sylvester RJ, van der Meijden AP, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 2006; 49: 466–75. 3 Sazuka T, Sakamoto S, Imamura Y et al. Relationship between post-void residual urine volume, preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma. Int. J. Urol. 2020; 27: 1024–30.
Journal Title: International Journal of Urology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!